Issued Patents 2021
Showing 1–12 of 12 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11208661 | Altering gene expression in modified T cells and uses thereof | Yangbing Zhao, Jiangtao Ren, Xiaojun Liu | 2021-12-28 |
| 11203758 | Altering gene expression in modified T cells and uses thereof | Yangbing Zhao, Jiangtao Ren, Xiaojun Liu | 2021-12-21 |
| 11161907 | Car-expressing cells against multiple tumor antigens and uses thereof | Daniel J. Powell, Jr. | 2021-11-02 |
| 11149076 | CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell | Hans Bitter, Jennifer Bordeaux, Barbara Brannetti, Jennifer Brogdon, Naveen Dakappagari +12 more | 2021-10-19 |
| 11090336 | Tn-MUC1 chimeric antigen receptor (CAR) T cell therapy | Avery D. Posey | 2021-08-17 |
| 11084880 | Anti-BCMA chimeric antigen receptor | Jennifer Brogdon, Eugene Choi, Hilmar Erhard Ebersbach, David Glass, Heather Huet +9 more | 2021-08-10 |
| 11034749 | Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof | Saar Gill, Michael Klichinsky | 2021-06-15 |
| 11028177 | Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells | Jennifer Brogdon, Saar Gill, Michael D. Kalos, Andreas Loew, John Scholler | 2021-06-08 |
| 11028143 | Enhanced antigen presenting ability of RNA CAR T cells by co-introduction of costimulatory molecules | Yangbing Zhao, Devon Shedlock, Xiaojun Liu | 2021-06-08 |
| 11001805 | ICOS critically regulates the expansion and function of inflammatory human Th17 cells | James L. Riley, Chrystal Paulos, Bruce L. Levine | 2021-05-11 |
| 10981969 | Switch costimulatory receptors | Yangbing Zhao | 2021-04-20 |
| 10927184 | Treatment of cancer using humanized anti-CD19 chimeric antigen receptor | Jennifer Brogdon, Andreas Loew, Marcela Maus, John Scholler | 2021-02-23 |